ResearchMoz

China Human Immunoglobulin (pH4) for Intravenous Injection Industry Research Report 2013

QYResearch
Published Date » 2013-01-30
No. Of Pages » 187
   
 This report has firstly introduced Human Immunoglobulin (pH4) for Intravenous Injection definition classification industry chain etc related information. Then introduced Human Immunoglobulin (pH4) for Intravenous Injection manufacturing technology and product specifications, And then summary statistics China major Human Immunoglobulin (pH4) for Intravenous Injection manufacturers 2010-2016 Human Immunoglobulin (pH4) for Intravenous Injection capacity production supply demand shortage and Human Immunoglobulin (pH4) for Intravenous Injection selling price cost gross margin and production value, and also introduced China 25 manufacturers company basic information, 2010-2016 Human Immunoglobulin (pH4) for Intravenous Injection capacity production price cost gross margin production...
Table of Contents

Chapter One Human Immunoglobulin (pH4) for Intravenous Injection Industry Overview 1
1.1 Definition 1
1.2 Classification Application Working Principle 2
1.3 Industry Chain Structure 6
1.4 Market Status and Development Trend 10
1.4.1 Industry Competition Pattern 10
1.4.2 China Market Status 12
1.4.3 China Market Prospect 14
1.5 Policy Analysis 16

Chapter Two Human Immunoglobulin (pH4) for Intravenous Injection Manufacturing Process and Cost Analysis 25
2.1 Product Specifications Analysis 25
2.2 Manufacturing Process Analysis 28
2.3 Cost Structure Analysis 32
2.4 Raw Materials and Equipments Overview 33
2.5 Technical Trend and Difficulties 33

Chapter Three Human Immunoglobulin (pH4) for Intravenous Injection Production Supply Sales Demand Market Status and Forecast 34
3.1 Human Immunoglobulin (pH4) for Intravenous Injection Capacity Production Overview 34
3.2 Human Immunoglobulin (pH4) for Intravenous Injection Guangdong Guizhou Shanghai Sichuan Shandong Henan Etc Regional Production Overview 41
3.3 Human Immunoglobulin (pH4) for Intravenous Injection Capacity Utilization Rate 46
3.4Human Immunoglobulin (pH4) for Intravenous Injection Demand Overview 48
3.5Human Immunoglobulin (pH4) for Intravenous Injection Supply Demand Relationship 50
3.6 Human Immunoglobulin (pH4) for Intravenous Injection Cost Price Production Value Gross Margin 50
3.7 Human Immunoglobulin (pH4) for Intravenous Injection Import Export Consumption 51

Chapter Four Human Immunoglobulin (pH4) for Intravenous Injection Key Manufacturers Analysis 52
4.1 Shanghai Institute of Biological Products Co.,Ltd. 54
4.2 Hualan Bio (002007) 59
4.3 CTBB 64
4.4 Ronsen Pharmaceutical 68
4.5 Shanxi Kangbao Biological Product Co.,Ltd. 75
4.6 Shanghai RAAS (002252) 79
4.7Guizhou Taibang Biological Products Co.,Ltd. 84
4.8 Shenzhen Weiwuguangming Biological Products Co.,Ltd. 90
4.9 Tonrol Pharmaceutical 95
4.10 Banghe Pharmaceutical Co.,Ltd. 101
4.11 Sichuan Yuanda Shuyang Pharmaceutical Co.,Ltd. 104
4.12 Guangdong Shuanglin Bio-pharmacy Co.,Ltd. 110
4.13 Boya Biological (300294) 115
4.14 Wuhan Institute of Biological Products Co.,Ltd. 120
4.15 PAFC 125
4.16 Shanghai Xinxing Medicine Co.,Ltd. 130
4.17 Wuhan Zhongyuan Ruide Biological Products Co.,Ltd. 135
4.18 Guangdong Weilun Biological Pharmaceutical Co.,Ltd. 140
4.19 Greencross(China) 144
4.20 Guizhou Zhongtai Biological S&T Co.,Ltd. 148
4.21 Lanzhou Institute of Biological Products Co.,Ltd. 150
4.22 Xi’an Huitian Blood Products Co.,Ltd. 154
4.23 Hunan Unisplendour Guhan Nanyue-pharmaceutical Co.,Ltd. (000590) 157
4.25 Haikang Biological Products Co.,Ltd. 162
4.26Walvax Biotechnology Co.,Ltd. (300142) (Hebei Daan) 166

Chapter Five Human Immunoglobulin (pH4) for Intravenous Injection Project Investment Feasibility Analysis 169
5.1 Human Immunoglobulin (pH4) for Intravenous Injection Project SWOT Analysis 169
5.2 200K Bottle/Year Human Immunoglobulin (pH4) for Intravenous Injection (2.5g/Bottle) Project Feasibility Analysis 171
5.2.1 Project Name 171
5.2.2 Project Capacity 171
5.2.3 Project Key Buildings 171
5.2.4 Project Schedule 172
5.2.5 Project Investment Return Analysis 172

Chapter Six Human Immunoglobulin (pH4) for Intravenous Injection Industry Research Conclusions 173

List of Tables


Figure Human Immunoglobulin (pH4) for Intravenous Injection Product Picture 1
Table China 8 Type Human Immunoglobulin (pH4) for Intravenous Injection Price Table (RMB/Bottle) 2
Table 2012 Shandong Province Adjustment Human Immunoglobulin (pH4) for Intravenous Injection Price (RMB/Bottle) Note 3
Figure Blood Products Industry Chain Structure 6
Figure Human Immunoglobulin (pH4) for Intravenous Injection Industry Chain Structure 7
Table Blood Products Industry Operating Model and Business Flow 9
Table Blood Products Raw materials procurement, Research and development, Production, Quality inspection and Sales system 9
Figure 2005-2011 China Blood Products Industry Revenue (100 Million RMB) and Growth Rate 11
Figure 2002-2012 China Plasma Volume (Ton) and Growth Rate 12
Figure China Blood Products Plasma Station Number Regional Distribution 12
Figure 2012 China Key Blood Products Manufacturers Plasma Station Numbers Comparison 13
Table China Key Blood Products Health Care Coverage Table 14
Figure Blood Products Industry Supervision System 18
Table Human Immunoglobulin (pH4) for Intravenous Injection Industry Policies List 22
Table Shanghai Feb 2010 Human Immunoglobulin (pH4) for Intravenous Injection Retail Price (RMB/Bottle) List 24
Table Human Immunoglobulin (pH4) for Intravenous Injection Product Specifications List 26
Figure Human Immunoglobulin (pH4) for Intravenous Injection etc Key Blood Products Manufacturing Process Flow 28
Figure Human Immunoglobulin (pH4) for Intravenous Injection 7-8 Months  production Cycle 30
Figure Single Pulp Blood Collecting Flow 30
Figure Blood Products Separation Process 31
Figure Human Immunoglobulin (pH4) for Intravenous Injection (IVIG) Manufacturing Process Flow 31
Figure Human Immunoglobulin (pH4) for Intravenous Injection Cost Structure 32
Table Human Immunoglobulin (pH4) for Intravenous Injection Product Line Equipments List 33
Table 2010-2016 China 25 Manufacturers Human Immunoglobulin (pH4) for Intravenous Injection (2.5g/Bottle) Capacity and Total Capacity (10K Bottle) List 34
Table 2010-2016 China 25 Manufacturers Human Immunoglobulin (pH4) for Intravenous Injection Capacity Market Share List 35
Figure 2012 China 25 Manufacturers Human Immunoglobulin (pH4) for Intravenous Injection Capacity Market Share 37
Table 2010-2016 China 25 Manufacturers Human Immunoglobulin (pH4) for Intravenous Injection (2.5g/Bottle) Production and Total Production (10K Bottle) List 38
Table 2010-2016 China 25 Manufacturers Human Immunoglobulin (pH4) for Intravenous Injection Production Market Share List 39
Figure 2012 China 25 Manufacturers Human Immunoglobulin (pH4) for Intravenous Injection Production Market Share 41
Table China Key Blood Products Suppliers Profiles 41
Table 2010-2016 China Guangdong Guizhou Shanghai Sichuan Shandong Henan Etc Regional Human Immunoglobulin (pH4) for Intravenous Injection Capacity and Total Capacity (10K Bottle) List 42
Table 2010-2016 China Guangdong Guizhou Shanghai Sichuan Shandong Henan Etc Regional Human Immunoglobulin (pH4) for Intravenous Injection Capacity Market Share List 43
Figure 2012 China Guangdong Guizhou Shanghai Sichuan Shandong Henan Etc Regional Human Immunoglobulin (pH4) for Intravenous Injection Capacity Market Share 44
Table 2010-2016 China Guangdong Guizhou Shanghai Sichuan Shandong Henan Etc Regional Human Immunoglobulin (pH4) for Intravenous Injection Production and Total Production (10K Bottle) List 44
Table 2010-2016 China Guangdong Guizhou Shanghai Sichuan Shandong Henan Etc Regional Human Immunoglobulin (pH4) for Intravenous Injection Production Market Share List 45
Figure 2012 China Guangdong Guizhou Shanghai Sichuan Shandong Henan Etc Regional Human Immunoglobulin (pH4) for Intravenous Injection Production Market Share 46
Figure 2010-2016 China Human Immunoglobulin (pH4) for Intravenous Injection Capacity Production (10K Bottle) and Growth Rate 46
Table 2010-2016 China Human Immunoglobulin (pH4) for Intravenous Injection Capacity Utilization Rate List 47
Table 2012 China Human Immunoglobulin (pH4) for Intravenous Injection Capacity Utilization Rate List 47
Figure China Blood Products Plasma Volume Development Trend 48
Figure China Blood Products Plasma Volume and Demand (Ton) 49
Table China and Developed Countries Human Immunoglobulin (pH4) for Intravenous Injection Consumption Comparison 49
Table 2010-2016 China Human Immunoglobulin (pH4) for Intravenous Injection Demand (10K Bottle) List 49
Table 2010-2016 China Human Immunoglobulin (pH4) for Intravenous Injection Supply Demand Shortage (10K Bottle) List 50
Table 2010-2016 China Human Immunoglobulin (pH4) for Intravenous Injection Production (10K Bottle) Price Cost Gross (RMB/Bottle) Production Value (10K RMB) Gross Margin List 50
Table 2010-2016 China Human Immunoglobulin (pH4) for Intravenous Injection Import Export Consumption (10K Bottle) List 51
Table Blood Products Key Manufacturers Plasma Station Numbers List 52
Figure China Blood Products Suppliers Plasma Station Distribution 54
Table Shanghai Institute of Biological Products Co.,Ltd. Company Information Table(Product Specification Application Place of Production Capacity Expansion Plan Market Position Contact Information etc 13 Items) 55
Figure Shanghai Institute of Biological Products Co.,Ltd. Human Immunoglobulin (pH4) for Intravenous Injection 56
Table Shanghai Institute of Biological Products Co.,Ltd. Human Immunoglobulin (pH4) for Intravenous Injection Production Specifications List 56
Table 2010-2016 Shanghai Institute of Biological Products Co.,Ltd. Human Immunoglobulin (pH4) for Intravenous Injection Capacity Production (10K Bottle) Price Cost Gross (RMB/Bottle) Production Value (10K RMB) Gross Margin List 58
Figure 2010-2016 Shanghai Institute of Biological Products Co.,Ltd. Human Immunoglobulin (pH4) for Intravenous Injection Capacity Production (10K Bottle) and Growth Rate 59
Table Hualan Bio Company Information Table(Product Specification Application Place of Production Capacity Expansion Plan Market Position Contact Information etc 13 Items) 59
Figure 2009-2014 Hualan Bio Plasma Volume (Ton) Forecast 60
Figure Hualan Bio Human Immunoglobulin (pH4) for Intravenous Injection 61
Table Hualan Bio Human Immunoglobulin (pH4) for Intravenous Injection Production Specifications List 61
Table 2010-2016 Hualan Bio Human Immunoglobulin (pH4) for Intravenous Injection Capacity Production (10K Bottle) Price Cost Gross (RMB/Bottle) Production Value (10K RMB) Gross Margin List 63
Figure 2010-2016 Hualan Bio Human Immunoglobulin (pH4) for Intravenous Injection Capacity Production (10K Bottle) and Growth Rate 63
Table CTBB Company Information Table(Product Specification Application Place of Production Capacity Expansion Plan Market Position Contact Information etc 13 Items) 64
Figure CTBB Human Immunoglobulin (pH4) for Intravenous Injection 66
Table CTBB Human Immunoglobulin (pH4) for Intravenous Injection Production Specifications List 66
Table 2010-2016 CTBB Human Immunoglobulin (pH4) for Intravenous Injection Capacity Production (10K Bottle) Price Cost Gross (RMB/Bottle) Production Value (10K RMB) Gross Margin List 67
Figure 2010-2016 CTBB Human Immunoglobulin (pH4) for Intravenous Injection Capacity Production (10K Bottle) and Growth Rate 68
Table Ronsen Pharmaceutical Company Information Table(Product Specification Application Place of Production Capacity Expansion Plan Market Position Contact Information etc 13 Items) 68
Figure Ronsen Pharmaceutical Human Immunoglobulin (pH4) for Intravenous Injection 70
Figure Ronsen Pharmaceutical Freeze Drying Human Immunoglobulin (pH4) for Intravenous Injection 70
Table Ronsen Pharmaceutical Human Immunoglobulin (pH4) for Intravenous Injection Production Specifications List 71
Table Ronsen Pharmaceutical Freeze Drying Human Immunoglobulin (pH4) for Intravenous Injection Production Specifications List 73
Table 2010-2016 Ronsen Pharmaceutical Human Immunoglobulin (pH4) for Intravenous Injection Capacity Production (10K Bottle) Price Cost Gross (RMB/Bottle) Production Value (10K RMB) Gross Margin List 74
Figure 2010-2016 Ronsen Pharmaceutical Human Immunoglobulin (pH4) for Intravenous Injection Capacity Production (10K Bottle) and Growth Rate 74
Table Shanxi Kangbao Biological Product Co.,Ltd. Company Information Table(Product Specification Application Place of Production Capacity Expansion Plan Market Position Contact Information etc 13 Items) 75
Figure Shanxi Kangbao Biological Product Co.,Ltd. Human Immunoglobulin (pH4) for Intravenous Injection 76
Table Shanxi Kangbao Biological Product Co.,Ltd. Human Immunoglobulin (pH4) for Intravenous Injection Production Specifications List 76
Table 2010-2016 Shanxi Kangbao Biological Product Co.,Ltd. Human Immunoglobulin (pH4) for Intravenous Injection (10g/Bottle) Capacity Production (10K Bottle) Price Cost Gross (RMB/Bottle) Production Value (10K RMB) Gross Margin List 78
Figure 2010-2016 Shanxi Kangbao Biological Product Co.,Ltd. Human Immunoglobulin (pH4) for Intravenous Injection Capacity Production (10K Bottle) and Growth Rate 79
Table Shanghai RAAS Company Information Table(Product Specification Application Place of Production Capacity Expansion Plan Market Position Contact Information etc 13 Items) 79
Figure 2007-2015 Shanghai RAAS Plasma Volume (Ton) and Growth Rate 81
Figure Shanghai RAAS Blood Products Human Immunoglobulin (pH4) for Intravenous Injection 81
Table Shanghai RAAS Blood Products Human Immunoglobulin (pH4) for Intravenous Injection Production Specifications List 81
Table 2010-2016 Shanghai RAAS Human Immunoglobulin (pH4) for Intravenous Injection Capacity Production (10K Bottle) Price Cost Gross (RMB/Bottle) Production Value (10K RMB) Gross Margin List 83
Figure 2010-2016 Shanghai RAAS Human Immunoglobulin (pH4) for Intravenous Injection Capacity Production (10K Bottle) and Growth Rate 84
Table Guizhou Taibang Biological Products Co.,Ltd. Company Information Table(Product Specification Application Place of Production Capacity Expansion Plan Market Position Contact Information etc 13 Items) 85
Figure Guizhou Taibang Biological Products Co.,Ltd. Human Immunoglobulin (pH4) for Intravenous Injection 86
Table Guizhou Taibang Biological Products Co.,Ltd. Human Immunoglobulin (pH4) for Intravenous Injection Production Specifications List 87
Table 2010-2016 Guizhou Taibang Biological Products Co.,Ltd. Human Immunoglobulin (pH4) for Intravenous Injection Capacity Production (10K Bottle) Price Cost Gross (RMB/Bottle) Production Value (10K RMB) Gross Margin List 89
Figure 2010-2016 Guizhou Taibang Biological Products Co.,Ltd. Human Immunoglobulin (pH4) for Intravenous Injection Capacity Production (10K Bottle) and Growth Rate 90
Table Shenzhen Weiwuguangming Biological Products Co.,Ltd. Company Information Table(Product Specification Application Place of Production Capacity Expansion Plan Market Position Contact Information etc 13 Items) 91
Figure Shenzhen Weiwuguangming Biological Products Co.,Ltd. Freeze Drying Human Immunoglobulin (pH4) for Intravenous Injection 92
Table Shenzhen Weiwuguangming Biological Products Co.,Ltd. Freeze Drying Human Immunoglobulin (pH4) for Intravenous Injection Production Specifications List 92
Table 2010-2016 Shenzhen Weiwuguangming Biological Products Co.,Ltd. Human Immunoglobulin (pH4) for Intravenous Injection Capacity Production (10K Bottle) Price Cost Gross (RMB/Bottle) Production Value (10K RMB) Gross Margin List 94
Figure 2010-2016 Shenzhen Weiwuguangming Biological Products Co.,Ltd. Human Immunoglobulin (pH4) for Intravenous Injection Capacity Production (10K Bottle) and Growth Rate 95
Table Tonrol Pharmaceutical Company Information Table(Product Specification Application Place of Production Capacity Expansion Plan Market Position Contact Information etc 13 Items) 95
Figure Tonrol Pharmaceutical Freeze Drying Human Immunoglobulin (pH4) for Intravenous Injection (PH4) 97
Table Tonrol Pharmaceutical Freeze Drying Human Immunoglobulin (pH4) for Intravenous Injection (PH4)Production Specifications List 97
Table 2010-2016 Tonrol Pharmaceutical Human Immunoglobulin (pH4) for Intravenous Injection Capacity Production (10K Bottle) Price Cost Gross (RMB/Bottle) Production Value (10K RMB) Gross Margin List 100
Figure 2010-2016 Tonrol Pharmaceutical Human Immunoglobulin (pH4) for Intravenous Injection Capacity Production (10K Bottle) and Growth Rate 101
Table Banghe Pharmaceutical Co.,Ltd. Company Information Table(Product Specification Application Place of Production Capacity Expansion Plan Market Position Contact Information etc 13 Items) 101
Figure Banghe Pharmaceutical Co.,Ltd. Human Immunoglobulin (pH4) for Intravenous Injection 102
Table Banghe Pharmaceutical Co.,Ltd. Human Immunoglobulin (pH4) for Intravenous Injection Production Specifications List 103
Table 2010-2016 Banghe Pharmaceutical Co.,Ltd. Human Immunoglobulin (pH4) for Intravenous Injection Capacity Production (10K Bottle) Price Cost Gross (RMB/Bottle) Production Value (10K RMB) Gross Margin List 103
Figure 2010-2016 Banghe Pharmaceutical Co.,Ltd. Human Immunoglobulin (pH4) for Intravenous Injection Capacity Production (10K Bottle) and Growth Rate 104
Table Sichuan Yuanda Shuyang Pharmaceutical Co.,Ltd. Company Information Table(Product Specification Application Place of Production Capacity Expansion Plan Market Position Contact Information etc 13 Items) 104
Figure Sichuan Yuanda Shuyang Pharmaceutical Co.,Ltd. Human Immunoglobulin (pH4) for Intravenous Injection 106
Table Sichuan Yuanda Shuyang Pharmaceutical Co.,Ltd. Human Immunoglobulin (pH4) for Intravenous Injection Production Specifications List 107
Table 2010-2016 Sichuan Yuanda Shuyang Pharmaceutical Co.,Ltd. Human Immunoglobulin (pH4) for Intravenous Injection Capacity Production (10K Bottle) Price Cost Gross (RMB/Bottle) Production Value (10K RMB) Gross Margin List 109
Figure 2010-2016 Sichuan Yuanda Shuyang Pharmaceutical Co.,Ltd. Human Immunoglobulin (pH4) for Intravenous Injection Capacity Production (10K Bottle) and Growth Rate 110
Table Guangdong Shuanglin Bio-pharmacy Co.,Ltd. Company Information Table(Product Specification Application Place of Production Capacity Expansion Plan Market Position Contact Information etc 13 Items) 110
Figure Guangdong Shuanglin Bio-pharmacy Co.,Ltd. Human Immunoglobulin (pH4) for Intravenous Injection 112
Table Guangdong Shuanglin Bio-pharmacy Co.,Ltd. Human Immunoglobulin (pH4) for Intravenous Injection Production Specifications List 112
Table 2010-2016 Guangdong Shuanglin Bio-pharmacy Co.,Ltd. Human Immunoglobulin (pH4) for Intravenous Injection Capacity Production (10K Bottle) Price Cost Gross (RMB/Bottle) Production Value (10K RMB) Gross Margin List 114
Figure 2010-2016 Guangdong Shuanglin Bio-pharmacy Co.,Ltd. Human Immunoglobulin (pH4) for Intravenous Injection Capacity Production (10K Bottle) and Growth Rate 115
Table Boya Biological Company Information Table(Product Specification Application Place of Production Capacity Expansion Plan Market Position Contact Information etc 13 Items) 115
Figure Boya Biological Human Immunoglobulin (pH4) for Intravenous Injection 117
Table Boya Biological Human Immunoglobulin (pH4) for Intravenous Injection Production Specifications List 117
Figure 2009-2013 Boya Biological Plasma Volume (Ton) Forecast 119
Table 2010-2016 Boya Biological Human Immunoglobulin (pH4) for Intravenous Injection Capacity Production (10K Bottle) Price Cost Gross (RMB/Bottle) Production Value (10K RMB) Gross Margin List 119
Figure 2010-2016 Boya Biological Human Immunoglobulin (pH4) for Intravenous Injection Capacity Production (10K Bottle) and Growth Rate 120
Table Wuhan Institute of Biological Products Co.,Ltd. Company Information Table(Product Specification Application Place of Production Capacity Expansion Plan Market Position Contact Information etc 13 Items) 120
Figure Wuhan Institute of Biological Products Co.,Ltd. Human Immunoglobulin (pH4) for Intravenous Injection 122
Table Wuhan Institute of Biological Products Co.,Ltd. Human Immunoglobulin (pH4) for Intravenous Injection Production Specifications List 122
Table 2010-2016 Wuhan Institute of Biological Products Co.,Ltd. Human Immunoglobulin (pH4) for Intravenous Injection Capacity Production (10K Bottle) Price Cost Gross (RMB/Bottle) Production Value (10K RMB) Gross Margin List 124
Figure 2010-2016 Wuhan Institute of Biological Products Co.,Ltd. Human Immunoglobulin (pH4) for Intravenous Injection Capacity Production (10K Bottle) and Growth Rate 125
Table PAFC Company Information Table(Product Specification Application Place of Production Capacity Expansion Plan Market Position Contact Information etc 13 Items) 125
Figure PAFC Human Immunoglobulin (pH4) for Intravenous Injection 127
Figure PAFC Freeze Drying Human Immunoglobulin (pH4) for Intravenous Injection 127
Table PAFC Human Immunoglobulin (pH4) for Intravenous Injection Production Specifications List 128
Table 2010-2016 PAFC Human Immunoglobulin (pH4) for Intravenous Injection )Capacity Production (10K Bottle) Price Cost Gross (RMB/Bottle) Production Value (10K RMB) Gross Margin List 129
Figure 2010-2016 PAFC Human Immunoglobulin (pH4) for Intravenous Injection Capacity Production (10K Bottle) and Growth Rate 129
Table Shanghai Xinxing Medicine Co.,Ltd. Company Information Table(Product Specification Application Place of Production Capacity Expansion Plan Market Position Contact Information etc 13 Items) 130
Figure Shanghai Xinxing Medicine Co.,Ltd. Human Immunoglobulin (pH4) for Intravenous Injection 131
Table Shanghai Xinxing Medicine Co.,Ltd. Human Immunoglobulin (pH4) for Intravenous Injection Production Specifications List 131
Figure Shanghai Xinxing Medicine Co.,Ltd. Freeze Drying Human Immunoglobulin (pH4) for Intravenous Injection 133
Table Shanghai Xinxing Medicine Co.,Ltd. Freeze Drying Human Immunoglobulin (pH4) for Intravenous Injection Production Specifications List 133
Table 2010-2016 Shanghai Xinxing Medicine Co.,Ltd. Human Immunoglobulin (pH4) for Intravenous Injection Capacity Production (10K Bottle) Price Cost Gross (RMB/Bottle) Production Value (10K RMB) Gross Margin List 134
Figure 2010-2016 Shanghai Xinxing Medicine Co.,Ltd. Human Immunoglobulin (pH4) for Intravenous Injection Capacity Production (10K Bottle) and Growth Rate 135
Table Wuhan Zhongyuan Ruide Biological Products Co.,Ltd. Company Information Table(Product Specification Application Place of Production Capacity Expansion Plan Market Position Contact Information etc 13 Items) 135
Figure Wuhan Zhongyuan Ruide Biological Products Co.,Ltd. Human Immunoglobulin (pH4) for Intravenous Injection 137
Table Wuhan Zhongyuan Ruide Biological Products Co.,Ltd. Human Immunoglobulin (pH4) for Intravenous Injection Production Specifications List 137
Table 2010-2016 Wuhan Zhongyuan Ruide Biological Products Co.,Ltd. Human Immunoglobulin (pH4) for Intravenous Injection Capacity Production (10K Bottle) Price Cost Gross (RMB/Bottle) Production Value (10K RMB) Gross Margin List 139
Figure 2010-2016 Wuhan Zhongyuan Ruide Biological Products Co.,Ltd. Human Immunoglobulin (pH4) for Intravenous Injection Capacity Production (10K Bottle) and Growth Rate 140
Table Guangdong Weilun Biological Pharmaceutical Co.,Ltd. Company Information Table(Product Specification Application Place of Production Capacity Expansion Plan Market Position Contact Information etc 13 Items) 140
Figure Guangdong Weilun Biological Pharmaceutical Co.,Ltd. Freeze Drying Human Immunoglobulin (pH4) for Intravenous Injection 142
Table Guangdong Weilun Biological Pharmaceutical Co.,Ltd. Freeze Drying Human Immunoglobulin (pH4) for Intravenous Injection Production Specifications List 142
Table 2010-2016 Guangdong Weilun Biological Pharmaceutical Co.,Ltd. Human Immunoglobulin (pH4) for Intravenous Injection Capacity Production (10K Bottle) Price Cost Gross (RMB/Bottle) Production Value (10K RMB) Gross Margin List 143
Figure 2010-2016 Guangdong Weilun Biological Pharmaceutical Co.,Ltd. Human Immunoglobulin (pH4) for Intravenous Injection Capacity Production (10K Bottle) and Growth Rate 144
Table Greencross(China) Company Information Table(Product Specification Application Place of Production Capacity Expansion Plan Market Position Contact Information etc 13 Items) 144
Figure Greencross(China) Human Immunoglobulin (pH4) for Intravenous Injection 146
Table Greencross(China) Human Immunoglobulin (pH4) for Intravenous Injection Production Specifications List 146
Table 2010-2016 Greencross(China) Human Immunoglobulin (pH4) for Intravenous Injection Capacity Production (10K Bottle) Price Cost Gross (RMB/Bottle) Production Value (10K RMB) Gross Margin List 147
Figure 2010-2016 Greencross(China) Human Immunoglobulin (pH4) for Intravenous Injection Capacity Production (10K Bottle) and Growth Rate 148
Table Guizhou Zhongtai Biological S&T Co.,Ltd. Company Information Table(Product Specification Application Place of Production Capacity Expansion Plan Market Position Contact Information etc 13 Items) 148
Table 2010-2016 Guizhou Zhongtai Biological S&T Co.,Ltd. Human Immunoglobulin (pH4) for Intravenous Injection Capacity Production (10K Bottle) Price Cost Gross (RMB/Bottle) Production Value (10K RMB) Gross Margin List 149
Figure 2010-2016 Guizhou Zhongtai Biological S&T Co.,Ltd. Human Immunoglobulin (pH4) for Intravenous Injection Capacity Production (10K Bottle) and Growth Rate 150
Table Lanzhou Institute of Biological Products Co.,Ltd. Company Information Table(Product Specification Application Place of Production Capacity Expansion Plan Market Position Contact Information etc 13 Items) 151
Figure Lanzhou Institute of Biological Products Co.,Ltd. Human Immunoglobulin (pH4) for Intravenous Injection 152
Table 2010-2016 Lanzhou Institute of Biological Products Co.,Ltd. Human Immunoglobulin (pH4) for Intravenous Injection Capacity Production (10K Bottle) Price Cost Gross (RMB/Bottle) Production Value (10K RMB) Gross Margin List 152
Figure 2010-2016 Lanzhou Institute of Biological Products Co.,Ltd. Human Immunoglobulin (pH4) for Intravenous Injection Capacity Production (10K Bottle) and Growth Rate 153
Table Xi’an Huitian Blood Products Co.,Ltd. Company Information Table(Product Specification Application Place of Production Capacity Expansion Plan Market Position Contact Information etc 13 Items) 154
Figure Xi’an Huitian Blood Products Co.,Ltd. Human Immunoglobulin (pH4) for Intravenous Injection 155
Table Xi’an Huitian Blood Products Co.,Ltd. Human Immunoglobulin (pH4) for Intravenous Injection Production Specifications List 155
Table 2010-2016 Xi’an Huitian Blood Products Co.,Ltd. Human Immunoglobulin (pH4) for Intravenous Injection Capacity Production (10K Bottle) Price Cost Gross (RMB/Bottle) Production Value (10K RMB) Gross Margin List 156
Figure 2010-2016 Xi’an Huitian Blood Products Co.,Ltd. Human Immunoglobulin (pH4) for Intravenous Injection Capacity Production (10K Bottle) and Growth Rate 157
Table Hunan Unisplendour Guhan Nanyue-pharmaceutical Co.,Ltd. Company Information Table(Product Specification Application Place of Production Capacity Expansion Plan Market Position Contact Information etc 13 Items) 157
Figure Hunan Unisplendour Guhan Nanyue-pharmaceutical Co.,Ltd. Human Immunoglobulin (pH4) for Intravenous Injection 159
Table Hunan Unisplendour Guhan Nanyue-pharmaceutical Co.,Ltd. Human Immunoglobulin (pH4) for Intravenous Injection Production Specifications List 159
Table 2010-2016 Hunan Unisplendour Guhan Nanyue-pharmaceutical Co.,Ltd. Human Immunoglobulin (pH4) for Intravenous Injection Capacity Production (10K Bottle) Price Cost Gross (RMB/Bottle) Production Value (10K RMB) Gross Margin List 161
Figure 2010-2016 Hunan Unisplendour Guhan Nanyue-pharmaceutical Co.,Ltd. Human Immunoglobulin (pH4) for Intravenous Injection Capacity Production (10K Bottle) and Growth Rate 162
Table Haikang Biological Products Co.,Ltd. Company Information Table(Product Specification Application Place of Production Capacity Expansion Plan Market Position Contact Information etc 13 Items) 162
Figure Haikang Biological Products Co.,Ltd. Human Immunoglobulin (pH4) for Intravenous Injection 164
Table Haikang Biological Products Co.,Ltd. Human Immunoglobulin (pH4) for Intravenous Injection Production Specifications List 164
Table 2010-2016 Haikang Biological Products Co.,Ltd. Human Immunoglobulin (pH4) for Intravenous Injection Capacity Production (10K Bottle) Price Cost Gross (RMB/Bottle) Production Value (10K RMB) Gross Margin List 165
Figure 2010-2016 Haikang Biological Products Co.,Ltd. Human Immunoglobulin (pH4) for Intravenous Injection Capacity Production (10K Bottle) and Growth Rate 166
Table Walvax Biotechnology Co.,Ltd. Company Information Table(Product Specification Application Place of Production Capacity Expansion Plan Market Position Contact Information etc 13 Items) 166
Figure Walvax Biotechnology Co.,Ltd. Subsudiaries and Their Products List 168
Table 2010-2016 Walvax Biotechnology Co.,Ltd. Human Immunoglobulin (pH4) for Intravenous Injection Capacity Production (10K Bottle) Price Cost Gross (RMB/Bottle) Production Value (10K RMB) Gross Margin List 168
Figure 2010-2016 Walvax Biotechnology Co.,Ltd. Human Immunoglobulin (pH4) for Intravenous Injection Capacity Production (10K Bottle) and Growth Rate 169
Table 2012 China Human Immunoglobulin (pH4) for Intravenous Injection Project SWOT Analysis List 170
Table 200K Bottle/Year Human Immunoglobulin (pH4) for Intravenous Injection (2.5g/Bottle) Project Schedule Table 172
Table 200K Bottle/Year Human Immunoglobulin (pH4) for Intravenous Injection (2.5g/Bottle) Project Investment Items List 172
Table 200K Bottle/Year Human Immunoglobulin (pH4) for Intravenous Injection (2.5g/Bottle) Project Investment Return and Feasibility Analysis List 173

List of Figures

Upcoming Reports:

Electrodes for Medical Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
By - Transparency Market Research
The electrodes used in medical devices transfer the ionic current energy into electrical current in the body. These currents can be amplified and have proved to be helpful in diagnosing various diseases. Medical electrodes comprises of a lead, metal and electrode conducting paste. Medical electrodes proceed with quantification of internal ionic currents and results in diagnosis of various ocular, nervous, cardiac and muscular disorders. The device works through provision of an electrical contact between apparatus used to monitor activities and patient.   The electrodes...
End-Of-Pipe Air Pollution Control Equipments Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast 2014 - 2020
By - Transparency Market Research
End-of-pipe is a technology deployed to decrease or eliminate emission of substance into the atmosphere that can harm human health or environment. Air pollution control is one of the major areas of pollution control, along with solid waste management, wastewater treatment and hazardous waste management. Air is said to be polluted when it contains harmful substances in high concentration and causes undesirable effects. End-of-pipe air pollution control equipment helps in reducing emission of harmful gases by cleaning exhaust and polluted air before it is emitted from factories or plants....
Synthetic Rubber Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018
By - Transparency Market Research
Synthetic rubber is produced by the polymerization of petroleum-derived monomers. Most synthetic rubbers are made up of two or more monomers and hence have the desired superior properties. There are over 200 varieties of synthetic rubber available. The most consumed forms of synthetic rubber include butadiene rubber (BR), acrylonitrile butadiene rubber (NBR), styrene butadiene rubber (SBR) and ethylene propylene diene monomer (EPDM). Synthetic rubber has been replacing natural rubber (NR) in a variety of applications due to its inherent advantages in terms of its stability and...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

High-sodium Diet Increases Risks of Cardiovascular Diseases in Type 2 Diabetics
Jul 24, 2014  
A new research has found relation between the amount of salt in diet of diabetics and their chances of suffering from cardiovascular diseases. The research has stated that diabetics who have a high-salt diet are on a higher risk of having a chronic heart disease as compared to the ones who eat less salt.  The study’s findings provide evidences that support the benefits of a...
Strides Arcolab Bags USFDA Approval for Transplant Drug
Jul 24, 2014  
Indian pharmaceutical company Strides Arcolab has received the approval of the USFDA to sell its transplant drug Tacrolimus in the US market. The capsule is an immune-suppressant that is used for preventing organ rejection that may occur in transplant surgeries of organs such as kidneys, heart or liver in some patients.  USFDA has allowed the sale of the tablets in 5 mg, 1 mg and 0.5...
Chinese manufacturing gauge gets a hike after months
Jul 24, 2014  
China manufacturing gauge has climbed to its 18-month high this month, which has boosted the government’s chance of meeting the target for economic growth set for 2014, by a percentage of 7.5. The Purchasing Managers Index (PMI) preliminary from Markit Economics and HSBC Holdings Plc was at 52.0 and its has topped the 51.0 median estimate. These numbers indicate an above 50 mark. The...
Paracetamol doesn’t speed recovery or reduce low back pain: Study
Jul 24, 2014  
Paracetamol, which has long since been prescribed as a painkiller for severe low back pain, is no better than placebo; findings of a recent study in Australia have shown. The trial that was published on Thursday found that the universally recommended painkiller neither speeds recovery nor reduces the pain. Paracetamol is merely acts as a placebo or dummy pills doing nothing to ease the...
Early Treatment to Cure HIV virus Might not be Effective
Jul 23, 2014  
According to a research study, the virus of AIDS, HIV has the capacity of creating invulnerable strongholds in the host’s body rapidly. This has dashed hopes of early treatment for the condition, which might have been helpful to cure the virus. In one case, a baby was thought to be cured with the new treatment after its birth, however, the virus emerged couple of years later. A...